OLEMA PHARMACEUTICALS INC
OLMA · NASDAQ
Updated at 2026-10-14 08:52:42
- Today's High
- $7.36
- Today’s Low
- $6.99
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $7.77
- Previous Close
- $7.36
- Volume
- 1.01M
- Market Cap
- $643.98M
- P/E Ratio
- --
- EPS
- $-2.11
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 780 BRANNAN STREET, SAN FRANCISCO, CA, UNITED STATES, 94103
- Country
- US
- Listing Date
- 2020-11-19
- Fiscal Year End
- December
- Shares Outstanding
- 87.35M
- CIK
- 0001750284
- Website
- olema.com
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company is headquartered in San Francisco, California.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$67.17M
2026-03-31
$57.86M
2025-12-31
$49.89M
2025-09-30
$45.87M
Net Income
2026-06-30
-$63.2M
2026-03-31
-$53.08M
2025-12-31
-$46.06M
2025-09-30
-$42.21M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.61
2026-03-31
$-0.52
2025-12-31
$-0.50
2025-09-30
$-0.49
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$63.09M
2026-03-31
-$52.97M
2025-12-31
-$45.87M
2025-09-30
-$42.17M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $67.17M | $57.86M | $49.89M | $45.87M |
| Net Income | -$63.2M | -$53.08M | -$46.06M | -$42.21M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.61 | $-0.52 | $-0.50 | $-0.49 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$63.09M | -$52.97M | -$45.87M | -$42.17M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.